Mortality risk stratification in severely anaemic Jehovah's Witness patients

The aim of this retrospective cohort study was to identify early risk factors of mortality and develop a mortality risk stratification instrument for severely anaemic Jehovah's Witness patients. It has been shown that Jehovah's Witness patients with the Auckland Anaemia Mortality Risk Scor...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Internal medicine journal 2012-03, Vol.42 (3), p.e1-e3
Hauptverfasser:	Beliaev, A. M., Marshall, R. J., Smith, W., Windsor, J. A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Anemia - drug therapy Anemia - epidemiology Cardiovascular Diseases - mortality Erythropoietin - therapeutic use Factor VIIa - therapeutic use Female Filgrastim Folic Acid - therapeutic use Granulocyte Colony-Stimulating Factor - therapeutic use Hemorrhage - mortality Hospital Mortality Hospitals, Public - statistics & numerical data Humans Infection - mortality Iron - therapeutic use Jehovah's Witness Jehovah's Witnesses Kidney Failure, Chronic - mortality Kidney Failure, Chronic - therapy Male Middle Aged mortality New Zealand - epidemiology Plasma Postoperative Complications - mortality Recombinant Proteins - therapeutic use Retrospective Studies Risk Assessment Risk Factors severe anaemia treatment refusal Vitamin B 12 - therapeutic use Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The aim of this retrospective cohort study was to identify early risk factors of mortality and develop a mortality risk stratification instrument for severely anaemic Jehovah's Witness patients. It has been shown that Jehovah's Witness patients with the Auckland Anaemia Mortality Risk Score (Auckland AMRS) of 0 to 3 had 4% mortality, Auckland AMRS 4 to 5 32%, Auckland AMRS 6 to 7 50% and Auckland AMRS 8 and above 83%. It is concluded that the Auckland AMRS predicts mortality of severely anaemic Jehovah's Witness patients.
ISSN:	1444-0903 1445-5994
DOI:	10.1111/j.1445-5994.2011.02699.x